Voyager Therapeutics, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2017 | $52.4M | $175.1M | $43.6M |
| Jun 2017 | $53.1M | $158.4M | $66.3M |
| Sep 2017 | $55.7M | $140.9M | $48.2M |
| Dec 2017 | $50.4M | $184.5M | $31.5M |
| Mar 2018 | $136.7M | $235.0M | $140.4M |
| Jun 2018 | $132.7M | $214.7M | $59.6M |
| Sep 2018 | $131.5M | $197.1M | $42.1M |
| Dec 2018 | $130.6M | $177.0M | $46.9M |
| Mar 2019 | $310.7M | $411.3M | $113.3M |
| Jun 2019 | $270.2M | $388.6M | $79.9M |
| Sep 2019 | $268.1M | $376.2M | $82.6M |
| Dec 2019 | $255.2M | $354.8M | $86.0M |
| Mar 2020 | $242.9M | $322.6M | $165.2M |
| Jun 2020 | $220.6M | $297.5M | $144.3M |
| Sep 2020 | $103.5M | $269.8M | $147.4M |
| Dec 2020 | $107.3M | $261.6M | $104.4M |
| Mar 2021 | $101.5M | $237.7M | $117.8M |
| Jun 2021 | $98.2M | $208.7M | $117.8M |
| Sep 2021 | $97.4M | $184.8M | $111.5M |
| Dec 2021 | $98.8M | $193.9M | $117.4M |
| Mar 2022 | $148.3M | $224.2M | $131.9M |
| Jun 2022 | $128.6M | $188.6M | $78.3M |
| Sep 2022 | $102.7M | $182.5M | $96.9M |
| Dec 2022 | $100.3M | $159.4M | $99.0M |
| Mar 2023 | $119.3M | $336.3M | $268.3M |
| Jun 2023 | $116.5M | $315.5M | $244.3M |
| Sep 2023 | $118.4M | $294.7M | $65.3M |
| Dec 2023 | $115.0M | $351.3M | $68.8M |
| Mar 2024 | $128.7M | $469.6M | $143.1M |
| Jun 2024 | $100.8M | $436.2M | $76.1M |
| Sep 2024 | $95.7M | $426.0M | $112.5M |
| Dec 2024 | $93.3M | $393.1M | $71.4M |
| Mar 2025 | $80.5M | $353.2M | $74.8M |
| Jun 2025 | $78.2M | $322.1M | $43.9M |
| Sep 2025 | $68.5M | $288.3M | $45.1M |
| Dec 2025 | $56.2M | $252.3M | $65.3M |
| Mar 2026 | $45.7M | $219.3M | $43.3M |
| Jun 2026 | $43.4M | $197.8M | $35.8M |